Analyst Recommendations

Piper Sandler analyst issues OVERWEIGHT recommendation for TSLA on April 10, 2024 04:42AM ET. The previous analyst recommendation was Overweight.TSLA was trading at $176.88 at issue of the...

April 10, 2024   TSLA 2.15%

Citigroup analyst issues BUY recommendation for BABA on April 9, 2024 08:47PM ET. The previous analyst recommendation was Buy.BABA was trading at $72.99 at issue of the analyst...

April 9, 2024   BABA -0.41%

Morgan Stanley analyst issues OVERWEIGHT recommendation for NVDA on April 9, 2024 06:25PM ET. The previous analyst recommendation was Overweight.NVDA was trading at $853.54 at issue of the...

April 9, 2024   NVDA 0.68%

Goldman Sachs analyst issues BUY recommendation for PCG on April 9, 2024 04:27PM ET. PCG was trading at $16.99 at issue of the analyst recommendation.The overall analyst consensus...

April 9, 2024   PCG -0.41%

Morgan Stanley analyst issues OVERWEIGHT recommendation for DKNG on April 9, 2024 11:40AM ET. The previous analyst recommendation was Overweight.DKNG was trading at $44.95 at issue of the...

April 9, 2024   DKNG 1.47%

Susquehanna analyst issues BUY recommendation for BABA on April 9, 2024 10:01AM ET. The previous analyst recommendation was Buy.BABA was trading at $72.7012 at issue of the analyst...

April 9, 2024   BABA -0.41%

Susquehanna analyst issues BUY recommendation for BABA on April 9, 2024 10:01AM ET. The previous analyst recommendation was Buy.BABA was trading at $72.7012 at issue of the analyst...

April 9, 2024   BABA -0.41%

Scotiabank analyst issues OUTPERFORM recommendation for CCJ on April 9, 2024 08:48AM ET. The previous analyst recommendation was Outperform.CCJ was trading at $47.9699 at issue of the analyst...

April 9, 2024   CCJ -4.04%

Scotiabank analyst issues OUTPERFORM recommendation for FCX on April 9, 2024 08:57AM ET. The previous analyst recommendation was Outperform.FCX was trading at $51.51 at issue of the analyst...

April 9, 2024   FCX -1.51%

RBC Capital analyst issues OUTPERFORM recommendation for CVE on April 9, 2024 07:57AM ET. The previous analyst recommendation was Outperform.CVE was trading at $21.45 at issue of the...

April 9, 2024   CVE 4.41%